Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Stem Cell Banking Market - Growing Prevalence of Cancer is a Primary Driver | Technavio

Technavio Research
Posted on: 26 Jan 18

The global stem cell banking market is expected to grow at a CAGR of close to 13% during the period 2018-2022, according to a new market research study by Technavio.

This press release features multimedia. View the full release here:

Technavio has published a new market research report on the global stem cell banking market 2018-2022 under their healthcare and life sciences library. (Graphic: Business Wire)

The report categorizes the global stem cell banking market by cell type, including adult stem cells, umbilical cord blood stem cells, and embryonic stem cell. The report also determines the geographic breakdown of the market in terms of detailed analysis and impact, which includes key geographies such as APAC, the Americas, and EMEA.

Save more with Technavio.  Buy 2 reports and get the third for free: View Technavio’s latest discounts and promotions

Market driver: growing prevalence of cancer

Abnormal gene function which involves mutations in the genes and additions or deletions of genetic materials that regulate gene activity, results in cancer. Gene expression is affected by alterations in the chemical mechanisms responsible for the production of gene proteins, in cancer cells. If these changes alter expression of other genes, secondary effects on the overall gene expression can be observed, which will lead to improper functioning of cellular components and signals leading to malignancy.

According to a senior analyst at Technavio for men’s health, women’s health, and genitourinaryresearch, “The prevalence of cancer across the globe have increased due to the rise in urbanization, sedentary lifestyle, and unbalanced diet. High body mass index, improper diet, lack of physical activity, and excess intake of alcohol and tobacco are the leading causes of cancer-related deaths.”

Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.

Market trend: rising demand for personalized medicines

The rising demand for personalized medicines is high in the market. Personalized medicines offer treatments based on individual characteristics, needs, and preferences. People are increasingly storing their stem cells for future treatments. To develop personalized medicines, research organizations are exploring stem cells. Owing to the benefits such as low risks of immune rejection and GvHD, no requirement of stem cell donors, and limited need for anti-rejection drugs, research organizations have explored ways to develop personalized medicines through the use of MSCs. Personalized medicines help in the effective treatment of various diseases such as diabetes and cancer.

Is your business on track for a successful future? Learn how Technavio can help

Technavio helps businesses anticipate changes in their marketplace, make proactive adjustments, and develop effective strategies to optimize their market positions.

Some of the contributors in the market

  • AMAG Pharmaceuticals
  • Cordlife
  • Cyro-Cell International
  • Esperite

With the presence of several vendors and expertise in the collection and storage of stem cells, the global stem cell banking market is highly competitive. Global vendors dominate the market through cross-country collaborations with the regional vendors. The collaborations mainly focus on local distributors that assist in increasing the regional sales of products and services. To expand their customer base, vendors entering the market offer innovative technologies and rely on digital media. In terms of product quality, features, and patent restriction, these vendors find it difficult to compete with established vendors.

Get a sample copy of the global stem cell banking market report free of cost

Access Technavio’s continuously growing men’s health, women’s health, and genitourinary research library and find expert analysis on hundreds of markets.

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at

View source version on

Business Wire

Last updated on: 26/01/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.